XML 26 R2.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED) (USD $)
In Millions, except Per Share data
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
EARNINGS        
Net Sales $ 5,434 $ 4,768 $ 10,445 $ 9,575
Cost of products sold 1,481 1,277 2,824 2,583
Marketing, selling and administrative 1,040 894 1,968 1,794
Advertising and product promotion 253 263 467 475
Research and development 923 822 1,858 1,732
Provision for restructuring 40 24 84 35
Equity in net income of affiliates (62) (85) (144) (182)
Other (income)/expense (31) (19) (169) 94
Total Expenses 3,644 3,176 6,888 6,531
Earnings Before Income Taxes 1,790 1,592 3,557 3,044
Provision for income taxes 483 324 883 675
Net Earnings 1,307 1,268 2,674 2,369
Net Earnings Attributable to Noncontrolling Interest 405 341 786 699
Net Earnings Attributable to Bristol-Myers Squibb Company $ 902 $ 927 $ 1,888 $ 1,670
Earnings per Common Share Attributable to Bristol-Myers Squibb Company:        
Basic $ 0.53 $ 0.54 $ 1.11 $ 0.97
Diluted $ 0.52 $ 0.53 $ 1.10 $ 0.96
Dividends declared per common share $ 0.33 $ 0.32 $ 0.66 $ 0.64